1. Academic Validation
  2. The selective 5-HT1B receptor inverse agonist SB-224289, potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo

The selective 5-HT1B receptor inverse agonist SB-224289, potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo

  • Ann N Y Acad Sci. 1998 Dec 15;861:270-1. doi: 10.1111/j.1749-6632.1998.tb10219.x.
L M Gaster 1 P Ham G F Joiner F D King K R Mulholland P A Wyman J J Hagan G W Price C Roberts C Routledge J Selkirk P D Slade D N Middlemiss
Affiliations

Affiliation

  • 1 SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, UK. Laramie_Gaster-1@sbphrd.com
Figures
Products